{"schema_version":"secwatch.filing_event.v1","accession":"0001301787-22-000038","form_type":"8-K","ticker":"BXC","cik":"0001301787","company_name":"BlueLinx Holdings Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.317300+00:00","generated_at":"2026-06-24T05:45:16.969010+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BlueLinx Q2 EPS $7.48 vs $11.61 YoY; specialty sales up 17% offset structural decline","bullets":["Net income $71M ($7.48 diluted EPS) vs $113M ($11.61) Q2 2021.","Net sales $1.2B (-5% YoY); specialty products $788M (+17%), structural $452M (-29%).","Adjusted EBITDA $112M (9.1% margin) vs $166M (12.7%); operating cash $101M, free cash $97M.","Net leverage at 0.9x; available liquidity $451M all-time high; share repurchase auth increased to $100M.","Q3 early view: specialty gross margins 22-23%; structural margins 18-19% including reversal of cost adjustment."],"urls":{"canonical":"https://secwatch.observer/filing/0001301787-22-000038","json":"https://secwatch.observer/filing/0001301787-22-000038.json","markdown":"https://secwatch.observer/filing/0001301787-22-000038.md","text":"https://secwatch.observer/filing/0001301787-22-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1301787/000130178722000038/0001301787-22-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1301787/000130178722000038/bxc-20220802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:45:16.969010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}